LINC00342: A Promising Protein Target for Drug Development (G150759)

Target Name: LINC00342

NCBI ID: G150759

LINC00342

Other Name(s): LOC150759 | long intergenic non-protein coding RNA 342 | NCRNA00342 | Long intergenic non-protein coding RNA 342

LINC00342: A Promising Protein Target for Drug Development

LINC00342 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the LINC subfamily of RNA-binding proteins, which are known for their ability to interact with RNA molecules. LINC00342 has been shown to play a role in a variety of biological processes, including cell signaling, tissue repair, and metabolism.

One of the most promising aspects of LINC00342 is its potential as a drug target. LINC00342 has been shown to interact with a variety of molecules, including transcription factors, RNA-binding proteins, and metabolic enzymes. This suggests that it may be a useful target for drugs that are designed to modulate these interactions.

In addition to its potential as a drug target, LINC00342 has also been shown to be a valuable biomarker for a variety of diseases. For example, LINC00342 has been shown to be downregulated in a variety of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. This suggests that it may be a useful biomarker for these diseases, and that targeting LINC00342 may be a promising strategy for developing new treatments.

Another potential application of LINC00342 is its role in tissue repair. LINC00342 has been shown to play a role in the repair of damaged tissue in the brain, heart, and kidneys. This suggests that it may be a useful target for drugs that are designed to promote tissue repair and regeneration.

In addition to its potential applications as a drug target and biomarker, LINC00342 is also of interest because of its structural biology. The structure of LINC00342 has been determined using X-ray crystallography, and it has been shown to have a unique fold that is distinct from other RNA-binding proteins. This suggests that LINC00342 may have unique functions that are not currently understood.

Overall, LINC00342 is a protein that has a great deal of potential as a drug target and biomarker. Its unique structure and interactions with a variety of molecules make it an attractive target for researchers who are working to develop new treatments for a variety of diseases. Further studies are needed to fully understand the functions of LINC00342 and its potential as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 342

The "LINC00342 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00342 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets